Legal & General Group PLC Arcutis Biotherapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 118,593 shares of ARQT stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,593

Previous 118,593 -0.0%

Holding current value

$1.76 Million

Previous $1.1 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $29,827 - $39,435	3,585 Added 3.12%	118,593 $1.1 Million
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $772,450 - $1.34 Million	106,692 Added 1282.97%	115,008 $1.07 Million
Q1 2024 May 14, 2024	SELL	$3.25 - $11.77 $734 - $2,660	-226 Reduced 2.65%	8,316 $82,000
Q4 2023 Feb 15, 2024	SELL	$1.84 - $4.82 $64,806 - $169,765	-35,221 Reduced 80.48%	8,542 $27,000
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $40,244 - $83,217	7,579 Added 20.95%	43,763 $232,000
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $143,801 - $287,220	19,148 Added 112.4%	36,184 $344,000
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $11,253 - $18,854	1,100 Added 6.9%	17,036 $187,000
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $10,093 - $14,749	723 Added 4.75%	15,936 $235,000
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $60,850 - $91,872	3,409 Added 28.88%	15,213 $291,000
Q2 2022 Aug 22, 2022	BUY	$16.33 - $22.2 $50,165 - $68,198	3,072 Added 35.18%	11,804 $252,000
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $95,416 - $134,117	4,949 Added 130.82%	8,732 $209,000
Q2 2021 Aug 12, 2021	SELL	$24.42 - $34.75 $13,431 - $19,112	-550 Reduced 12.69%	3,783 $103,000
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $46,957 - $70,964	1,919 Added 79.49%	4,333 $125,000
Q4 2020 Feb 12, 2021	BUY	$17.82 - $31.73 $4,579 - $8,154	257 Added 11.91%	2,414 $68,000
Q3 2020 Nov 13, 2020	BUY	$23.44 - $32.28 $13,735 - $18,916	586 Added 37.3%	2,157 $63,000
Q2 2020 Aug 14, 2020	SELL	$24.48 - $36.56 $1,126 - $1,681	-46 Reduced 2.84%	1,571 $48,000
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $29,914 - $59,667	1,617 New	1,617 $48,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $894M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Arcutis Biotherapeutics, Inc. Transaction History